489 related articles for article (PubMed ID: 31832993)
21. Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature.
Suchonwanit P; Iamsumang W; Leerunyakul K
J Dermatolog Treat; 2022 Mar; 33(2):643-648. PubMed ID: 32538225
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.
Mazzetti A; Moro L; Gerloni M; Cartwright M
J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549
[TBL] [Abstract][Full Text] [Related]
23. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.
Nobari NN; Roohaninasab M; Sadeghzadeh-Bazargan A; Goodarzi A; Behrangi E; Nikkhah F; Ghassemi M
Adv Clin Exp Med; 2023 Jul; 32(7):813-823. PubMed ID: 36897103
[TBL] [Abstract][Full Text] [Related]
24. [Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
Rubina VV; Korchevaia TA; Kravchenko LIa
Vestn Dermatol Venerol; 1986; (7):21-5. PubMed ID: 2945335
[No Abstract] [Full Text] [Related]
25. Acne: effect of hormones on pathogenesis and management.
Shaw JC
Am J Clin Dermatol; 2002; 3(8):571-8. PubMed ID: 12358558
[TBL] [Abstract][Full Text] [Related]
26. Minocycline for acne vulgaris: efficacy and safety.
Garner SE; Eady EA; Popescu C; Newton J; Li WA
Cochrane Database Syst Rev; 2003; (1):CD002086. PubMed ID: 12535427
[TBL] [Abstract][Full Text] [Related]
27. The effectiveness of combination therapies for androgenetic alopecia: A systematic review and meta-analysis.
Zhou Y; Chen C; Qu Q; Zhang C; Wang J; Fan Z; Miao Y; Hu Z
Dermatol Ther; 2020 Jul; 33(4):e13741. PubMed ID: 32478968
[TBL] [Abstract][Full Text] [Related]
28. A review of hormonal therapy for female pattern (androgenic) alopecia.
Scheinfeld N
Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
[TBL] [Abstract][Full Text] [Related]
29. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Chen L; Zhang J; Wang L; Wang H; Chen B
Aesthetic Plast Surg; 2020 Jun; 44(3):962-970. PubMed ID: 32166351
[TBL] [Abstract][Full Text] [Related]
30. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
31. Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men.
Hugo Perez BS
Med Hypotheses; 2004; 62(1):112-5. PubMed ID: 14729013
[TBL] [Abstract][Full Text] [Related]
32. A review of the treatment of male pattern hair loss.
York K; Meah N; Bhoyrul B; Sinclair R
Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
[No Abstract] [Full Text] [Related]
33. Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of Acne.
Kalabalik-Hoganson J; Frey KM; Ozdener-Poyraz AE; Slugocki M
Ann Pharmacother; 2021 Oct; 55(10):1290-1296. PubMed ID: 33533262
[TBL] [Abstract][Full Text] [Related]
34. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
[TBL] [Abstract][Full Text] [Related]
35. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
36. Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older.
Gold M
Expert Rev Clin Immunol; 2021 Apr; 17(4):301-308. PubMed ID: 33616473
[TBL] [Abstract][Full Text] [Related]
37. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
38. Management of androgenetic alopecia.
Tosti A; Camacho-Martinez F; Dawber R
J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
[TBL] [Abstract][Full Text] [Related]
39. Clascoterone for treatment of acne.
Manjaly C; Martinez J; Barbieri J; Mostaghimi A
Drugs Today (Barc); 2023 Feb; 59(2):71-81. PubMed ID: 36811407
[TBL] [Abstract][Full Text] [Related]
40. Antiandrogen therapy for skin and hair disease.
Harper JC
Dermatol Clin; 2006 Apr; 24(2):137-43, v. PubMed ID: 16677962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
